Prognostic stratification based on m5C regulators acts as a novel biomarker for immunotherapy in hepatocellular carcinoma.
Liu P, Zhu Z, Ma J, Wei L, Han Y, Shen E, Tan X, Chen Y, Cai C, Guo C, Peng Y, Gao Y, Liu Y, Huang Q, Gao L, Li Y, Jiang Z, Wu W, Liu Y, Zeng S, Li W, Feng Z, Shen H.
Liu P, et al. Among authors: liu y.
Front Immunol. 2022 Sep 9;13:951529. doi: 10.3389/fimmu.2022.951529. eCollection 2022.
Front Immunol. 2022.
PMID: 36159831
Free PMC article.